Biogen, Inc. (BIIB) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Amgen, Inc.

Gilead Sciences, Inc.

Halozyme Therapeutics, Inc.

Bio-Techne Corp.

Elanco Animal Health, Inc.

Illumina, Inc.

Biogen, Inc.

BioMarin Pharmaceutical, Inc.

Moderna, Inc.

Vaxcyte, Inc.

Immunovant, Inc.

Why is Biogen, Inc. ?

Negative results in Jun 26

ROCE(HY) Lowest at 4.58%
INTEREST COVERAGE RATIO(Q) Lowest at 819.2
RAW MATERIAL COST(Y) Grown by 10.96% (YoY)

With ROE of 10.01%, it has a fair valuation with a 1.72 Price to Book Value

The stock is trading at a premium compared to its peers' average historical valuations
Over the past year, while the stock has generated a return of 62.77%, its profits have risen by 8.4% ; the PEG ratio of the company is 2.3

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Biogen, Inc. for you?

High Risk, Low Return

Absolute

Risk Adjusted

Volatility

Biogen, Inc.

62.77%

-0.22

36.49%

S&P 500

22.36%

1.70

13.18%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

-2.11%

EBIT Growth (5y)

3.08%

EBIT to Interest (avg)

8.05

Debt to EBITDA (avg)

1.60

Net Debt to Equity (avg)

0.22

Sales to Capital Employed (avg)

0.41

Tax Ratio

15.58%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

100.00%

ROCE (avg)

11.77%

ROE (avg)

19.32%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

1.72

EV to EBIT

14.01

EV to EBITDA

10.59

EV to Capital Employed

1.63

EV to Sales

3.56

PEG Ratio

2.25

Dividend Yield

ROCE (Latest)

11.63%

ROE (Latest)

10.01%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Mildly Bearish

Mildly Bullish

RSI

No Signal

Bollinger Bands

Mildly Bearish

Mildly Bullish

Moving Averages

Mildly Bullish (Daily)

KST

Mildly Bearish

Mildly Bullish

Dow Theory

Mildly Bearish

OBV

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

4What is working for the Company

OPERATING CASH FLOW(Y)

Highest at USD 2,878.8 MM

NET SALES(Q)

Highest at USD 2,622.5 MM

-17What is not working for the Company

ROCE(HY)

Lowest at 4.58%

INTEREST COVERAGE RATIO(Q)

Lowest at 819.2

RAW MATERIAL COST(Y)

Grown by 10.96% (YoY

DEBT-EQUITY RATIO (HY)

Highest at 37.51 %

DEBTORS TURNOVER RATIO(HY)

Lowest at 4.31 times

INTEREST(Q)

Highest at USD 82.3 MM

OPERATING PROFIT(Q)

Lowest at USD 438.1 MM

OPERATING PROFIT MARGIN(Q)

Lowest at 25.71 %

NET PROFIT(Q)

At USD 352.08 MM has Fallen at -20.86%

Here's what is working for Biogen, Inc.

Operating Cash Flow

Highest at USD 2,878.8 MM and Grown

In each year in the last three years

MOJO Watch

The company has generated higher cash revenues from business operations

Operating Cash Flows (USD MM)

Net Sales

Highest at USD 2,622.5 MM

in the last five periods

MOJO Watch

Near term sales trend is positive

Net Sales (USD MM)

Depreciation

Highest at USD 236.1 MM

in the last five periods

MOJO Watch

The expenditure on assets done by the company may have gone into operation

Depreciation (USD MM)

Here's what is not working for Biogen, Inc.

Interest

At USD 82.3 MM has Grown at 21.75%

period on period (QoQ)

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (USD MM)

Interest Coverage Ratio

Lowest at 819.2

in the last five periods

MOJO Watch

The company's ability to manage interest payments is deteriorating

Operating Profit to Interest

Interest

Highest at USD 82.3 MM

in the last five periods and Increased by 21.75% (QoQ)

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (USD MM)

Operating Profit

Lowest at USD 438.1 MM

in the last five periods

MOJO Watch

Near term Operating Profit trend is negative

Operating Profit (USD MM)

Operating Profit Margin

Lowest at 25.71 %

in the last five periods

MOJO Watch

Company's profit margin has deteriorated

Operating Profit to Sales

Net Profit

At USD 352.08 MM has Fallen at -20.86%

over average net sales of the previous four periods of USD 444.9 MM

MOJO Watch

Near term Net Profit trend is negative

Net Profit (USD MM)

Debt-Equity Ratio

Highest at 37.51 %

in the last five Semi-Annual periods

MOJO Watch

The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio

Debtors Turnover Ratio

Lowest at 4.31 times

in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling Debtors has slowed

Debtors Turnover Ratio

Raw Material Cost

Grown by 10.96% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales